GRCE
Grace Therapeutics, Inc. Common Stock
GRCE
GRCE
10 hedge funds and large institutions have $1.06M invested in Grace Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VKH
1
Virtu KCG Holdings
New York
|
$52K |
2 |
2
Renaissance Technologies
New York
|
$63K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$1K |
Top Sellers
No sellers this quarter